Emzotamig
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF) . Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis[1].
Product Specifications
CAS Number
3037572-57-6
UNSPSC
12352100
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]WHO Drug Information, Vol. 39, No. 2, 2025.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS451739-03 5x 96 Tests
Human Laminin Receptor 1 (LAMR1) ELISA Kit
Sign In for Pricing
View Details MBS451739-04 10x 96 Tests
Human Laminin Receptor 1 (LAMR1) ELISA Kit
Sign In for Pricing
View Details LV632446 1.0 µg DNA
Olr312 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details